Colgate-Palmolive (CL) Holdings Cut by Wealthstreet Investment Advisors LLC

Wealthstreet Investment Advisors LLC lessened its position in Colgate-Palmolive (NYSE:CL) by 2.6% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 117,893 shares of the company’s stock after selling 3,200 shares during the period. Colgate-Palmolive accounts for 1.0% of Wealthstreet Investment Advisors LLC’s investment portfolio, making the stock its 23rd biggest position. Wealthstreet Investment Advisors LLC’s holdings in Colgate-Palmolive were worth $7,893,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Massachusetts Financial Services Co. MA boosted its stake in shares of Colgate-Palmolive by 11.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 32,560,326 shares of the company’s stock valued at $2,110,235,000 after purchasing an additional 3,397,667 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Colgate-Palmolive by 8.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 20,135,385 shares of the company’s stock valued at $1,304,974,000 after purchasing an additional 1,596,825 shares in the last quarter. OppenheimerFunds Inc. boosted its stake in shares of Colgate-Palmolive by 6.4% during the 2nd quarter. OppenheimerFunds Inc. now owns 6,785,987 shares of the company’s stock valued at $439,801,000 after purchasing an additional 405,430 shares in the last quarter. Fiera Capital Corp boosted its stake in shares of Colgate-Palmolive by 4.6% during the 2nd quarter. Fiera Capital Corp now owns 5,012,573 shares of the company’s stock valued at $324,865,000 after purchasing an additional 219,925 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec boosted its stake in shares of Colgate-Palmolive by 15.3% during the 2nd quarter. Caisse DE Depot ET Placement DU Quebec now owns 4,093,312 shares of the company’s stock valued at $265,288,000 after purchasing an additional 543,500 shares in the last quarter. 75.17% of the stock is currently owned by institutional investors and hedge funds.

NYSE:CL opened at $59.70 on Thursday. Colgate-Palmolive has a one year low of $57.41 and a one year high of $77.91. The company has a debt-to-equity ratio of 64.85, a quick ratio of 0.28 and a current ratio of 1.11. The stock has a market cap of $52.20 billion, a P/E ratio of 20.80, a price-to-earnings-growth ratio of 2.96 and a beta of 0.72.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 26th. The company reported $0.72 EPS for the quarter, hitting the consensus estimate of $0.72. Colgate-Palmolive had a net margin of 13.55% and a return on equity of 12,004.60%. The business had revenue of $3.85 billion for the quarter, compared to analyst estimates of $3.89 billion. During the same quarter in the previous year, the firm posted $0.73 earnings per share. Colgate-Palmolive’s quarterly revenue was down 3.2% on a year-over-year basis. Research analysts anticipate that Colgate-Palmolive will post 2.96 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 15th. Shareholders of record on Friday, October 19th will be issued a $0.42 dividend. The ex-dividend date of this dividend is Thursday, October 18th. This represents a $1.68 annualized dividend and a yield of 2.81%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.54%.

CL has been the topic of a number of research reports. Wells Fargo & Co lowered shares of Colgate-Palmolive to a “hold” rating in a research note on Tuesday, July 17th. UBS Group raised shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating and lifted their target price for the company from $70.00 to $75.00 in a research note on Wednesday, July 18th. Stifel Nicolaus cut their target price on shares of Colgate-Palmolive from $75.00 to $73.00 and set a “hold” rating on the stock in a research note on Monday, July 23rd. Macquarie lowered shares of Colgate-Palmolive from an “outperform” rating to a “neutral” rating and cut their target price for the company from $74.00 to $65.00 in a research note on Monday, July 30th. Finally, Barclays set a $64.00 price objective on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research note on Monday, July 30th. Four research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $68.06.

In other Colgate-Palmolive news, SVP John J. Huston sold 19,774 shares of Colgate-Palmolive stock in a transaction dated Friday, August 10th. The shares were sold at an average price of $65.56, for a total value of $1,296,383.44. Following the completion of the transaction, the senior vice president now directly owns 97,300 shares of the company’s stock, valued at $6,378,988. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Mukul Deoras sold 11,334 shares of Colgate-Palmolive stock in a transaction dated Monday, August 13th. The stock was sold at an average price of $65.10, for a total transaction of $737,843.40. Following the completion of the transaction, the insider now directly owns 32,625 shares of the company’s stock, valued at $2,123,887.50. The disclosure for this sale can be found here. Insiders sold 169,585 shares of company stock valued at $11,132,140 over the last ninety days. Corporate insiders own 1.02% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Read More: Why do corrections happen?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply